HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Activated expression of cardiac adenylyl cyclase 6 reduces dilation and dysfunction of the pressure-overloaded heart.

AbstractBACKGROUND AND OBJECTIVE:
Cardiac-directed adenylyl cyclase 6 (AC6) expression attenuates left ventricular (LV) hypertrophy and dysfunction in cardiomyopathy, but its effects in the pressure-overloaded heart are unknown.
METHODS:
Mice with cardiac-directed and regulated expression of AC6 underwent transaortic constriction (TAC) to induce LV pressure overload. Ten days prior to TAC, and for the duration of the 4 week study, cardiac myocyte AC6 expression was activated in one group (AC-On) but not the other (AC-Off). Multiple measures of LV systolic and diastolic function were obtained 4 weeks after TAC, and LV samples assessed for alterations in Ca2+ signaling.
RESULTS:
LV contractility, as reflected in the end-systolic pressure-volume relationship (Emax), was increased (p=0.01) by activation of AC6 expression. In addition, diastolic function was improved (p<0.05) and LV dilation was reduced (p<0.05). LV samples from AC-On mice showed reduced protein expression of sodium/calcium exchanger (NCX1) (p<0.05), protein phosphatase 1 (PP1) (p<0.01), and increased phosphorylation of phospholamban (PLN) at Ser16 (p<0.05). Finally, sarcoplasmic reticulum (SR) Ca2+ content was increased in cardiac myocytes isolated from AC-On mice (p<0.05).
CONCLUSIONS:
Activation of cardiac AC6 expression improves function of the pressure-overloaded and failing heart. The predominant mechanism for this favorable adaptation is improved Ca2+ handling, a consequence of increased PLN phosphorylation, reduced NCX1, reduced PP1 expression, and increased SR Ca2+ content.
AuthorsYasuo Sugano, N Chin Lai, Mei Hua Gao, Amy L Firth, Jason X-J Yuan, Wilbur Y W Lew, H Kirk Hammond
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 405 Issue 3 Pg. 349-55 (Feb 18 2011) ISSN: 1090-2104 [Electronic] United States
PMID21195051 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
CopyrightCopyright © 2011. Published by Elsevier Inc.
Chemical References
  • Calcium-Binding Proteins
  • NCX1 protein, mouse
  • Receptors, Neuropeptide Y
  • Sodium-Calcium Exchanger
  • phospholamban
  • Caffeine
  • neuropeptide Y4 receptor
  • Adenylyl Cyclases
  • adenylyl cyclase 6
  • Calcium
Topics
  • Adenylyl Cyclases (biosynthesis, genetics)
  • Animals
  • Caffeine (pharmacology)
  • Calcium (metabolism)
  • Calcium-Binding Proteins (metabolism)
  • Dilatation, Pathologic (enzymology, physiopathology)
  • Enzyme Activation
  • Hypertrophy, Left Ventricular (enzymology, physiopathology)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Phosphorylation
  • Pressure
  • Receptors, Neuropeptide Y (metabolism)
  • Sodium-Calcium Exchanger (metabolism)
  • Ventricular Dysfunction, Left (enzymology, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: